Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%)

被引:104
作者
Ivanovic, Z
Hermitte, F
De La Grange, PB
Dazey, B
Belloc, F
Lacombe, F
Vezon, G
Praloran, V
机构
[1] Univ Bordeaux 2, Lab Studies Hematopoiesis Mol & Funct Aspects, F-33076 Bordeaux, France
[2] Estab Aquitaine Limousin Reg Ctr, Bordeaux, France
[3] Haut Leveque Hosp, Hematol Lab, Pessac, France
关键词
severe combined immunodeficiency-repopulating cells; NOD/SCID stem cells; IL-3; hypoxia; cord blood; ex vivo expansion;
D O I
10.1634/stemcells.22-5-716
中图分类号
Q813 [细胞工程];
学科分类号
摘要
In the present work, we tested the hypothesis that liquid cultures (LCs) of cord blood CD34(+) cells at an appropriate low O-2 concentration could simultaneously allow colony-forming cell (CFC) expansion and nonobese diabetic/severe combined immunodeficiency mice-repopulating cell (SRC) maintenance. We first found that 3% was the minimal O-2 concentration, still allowing the same rate of CFC expansion as at 20% O-2. We report here that 7-day LCs of cord blood CD34(+) cells at 3% O-2 maintain SRC better than at 20% O-2 and allow a similar amplification of CFCs (35- to 50-fold) without modifying the CD34(+) cell proliferation. Their phenotypic profile (antigens: HLA-DR, CD117, CD33, CD13, CD11b, CD14, CD15, and CD38) was not modified, with exception of CD133, whose expression was lower at 3% O-2. These results suggest that low O-2 concentrations similar to those found in bone marrow participates in the regulation of hematopoiesis by favoring stem cell-renewing divisions. This expansion method that avoids stem cell exhaustion could be of paramount interest in hematopoietic transplantation by allowing the use of small-size grafts in adults.
引用
收藏
页码:716 / 724
页数:9
相关论文
共 33 条
[21]  
KOLLER MR, 1992, BLOOD, V80, P403
[22]   The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters [J].
McCoy, KD ;
Ahmed, N ;
Tan, AS ;
Berridge, MV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17276-17282
[23]  
McNiece I, 2000, BLOOD, V96, P3001
[24]   Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo [J].
Neildez-Nguyen, TMA ;
Wajcman, H ;
Marden, MC ;
Bensidhoum, M ;
Moncollin, V ;
Giarratana, MC ;
Kobari, L ;
Thierry, D ;
Douay, L .
NATURE BIOTECHNOLOGY, 2002, 20 (05) :467-472
[25]   Ex vivo expansion marginally amplifies repopulating cells from baboon peripheral blood mobilized CD34+ cells [J].
Norol, F ;
Drouet, M ;
Pflumio, F ;
Léonardi, M ;
Mourcin, F ;
Debili, N ;
Job, A ;
Vainchenker, W ;
Kuentz, M ;
Hérodin, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) :924-934
[26]  
Peters SO, 1996, BLOOD, V87, P30
[27]   Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion:: Evidence for the amplification and self-renewal of repopulating stem cells [J].
Piacibello, W ;
Sanavio, F ;
Severino, A ;
Danè, A ;
Gammaitoni, L ;
Fagioli, F ;
Perissinotto, E ;
Cavalloni, G ;
Kollet, O ;
Lapidot, T ;
Aglietta, M .
BLOOD, 1999, 93 (11) :3736-3749
[28]   Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation [J].
Piacibello, W ;
Sanavio, F ;
Garetto, L ;
Severino, A ;
Dané, A ;
Gammaitoni, L ;
Aglietta, M .
LEUKEMIA, 1998, 12 (05) :718-727
[29]   Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells [J].
Reiffers, J ;
Cailliot, C ;
Dazey, B ;
Attal, M ;
Caraux, J ;
Boiron, JM .
LANCET, 1999, 354 (9184) :1092-1093
[30]  
ROTTEM M, 1994, BLOOD, V84, P2489